Open access
Open access
Powered by Google Translator Translator

Heart Failure/Transplantation

Cardiogenic Shock | Emergency department-focused management

25 Jan, 2023 | 11:21h | UTC

Cardiogenic Shock: Emergency Department-Focused Management – emDocs

Related: The medical treatment of cardiogenic shock – Journal of Intensive Medicine

 


2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis

24 Jan, 2023 | 14:29h | UTC

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Key Points: 2023 ACC Expert Consensus on Cardiac Amyloidosis – American College of Cardiology

News Release: ACC Expert Consensus Decision Pathway Focuses on Diagnosis and Management of Cardiac Amyloidosis – American College of Cardiology

 

Commentary on Twitter

 


Review | Getting ahead of the game: in-hospital initiation of HFrEF therapies

20 Jan, 2023 | 14:24h | UTC

Getting ahead of the game: in-hospital initiation of HFrEF therapies – European Heart Journal Supplements

 


Cohort Study | Left atrial mechanical dysfunction and risk of ischemic stroke in people without atrial fibrillation

20 Jan, 2023 | 14:23h | UTC

Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke: A Prospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries:

Left Atrial Dysfunction and Risk for Ischemic Stroke – American College of Cardiology

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke – TCTMD

Left Atrial Reservoir Strain Plus CHA₂DS₂-VASc Ups Stroke Prediction – HealthDay

 

Commentary on Twitter

 


RCT | No difference in survival with Torsemide vs. Furosemide after discharge of patients hospitalized with heart failure

19 Jan, 2023 | 14:26h | UTC

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: TRANSFORM-HF—Can We Close the Loop on Diuretics in Heart Failure? – JAMA (free for a limited period)

News Release: Comparison of diuretics shows no difference in heart failure survival – NIH/National Heart, Lung and Blood Institute

 

Commentary on Twitter

 


Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments

17 Jan, 2023 | 13:08h | UTC

Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments – European Heart Journal

 

Commentary on Twitter

 


A multidisciplinary approach for the emergency care of patients with left ventricular assist devices

12 Jan, 2023 | 12:49h | UTC

A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide – Frontiers in Cardiovascular Medicine

 


Review | Predictors of early heart failure rehospitalization among older adults with preserved and reduced ejection fraction

11 Jan, 2023 | 13:58h | UTC

Predictors of early heart failure rehospitalization among older adults with preserved and reduced ejection fraction: A review and derivation of a conceptual model – Heart & Lung

 


Cohort Study | Risk of heart failure in congenital heart disease

10 Jan, 2023 | 14:14h | UTC

Risk of Heart Failure in Congenital Heart Disease: A Nationwide Register-based Cohort Study – Circulation

News Release: Heart failure more common in heart defect survivors starting at young age – American Heart Association

 


The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies

9 Jan, 2023 | 14:10h | UTC

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies – European Heart Journal

 

Commentary on Twitter

 


AHA Scientific Statement | Complementary and alternative medicines in the management of heart failure.

9 Dec, 2022 | 13:40h | UTC

Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association – Circulation

News Release: Some benefits, potential risks with alternative medicines for heart failure – American Heart Association

 


ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.

8 Dec, 2022 | 12:57h | UTC

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison – ESC Heart Failure

Original Guidelines:

#ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

 


Review | How to assess systemic venous congestion with point of care ultrasound.

6 Dec, 2022 | 13:37h | UTC

How to assess systemic venous congestion with point of care ultrasound – European Heart Journal – Cardiovascular Imaging

 


SR | Methamphetamine-associated heart failure.

5 Dec, 2022 | 00:06h | UTC

Methamphetamine-associated heart failure: a systematic review of observational studies – Heart

Editorial: Too much heterogeneity: envisioning a new approach to methamphetamine associated heart failure – Heart

News Release: Prevalence of ‘meth’ heart failure now in wide range of social class and racial groups – BMJ Newsroom

Commentaries: Prevalence of Methamphetamine-Related Heart Failure Increasing – HealthDay

 


Fluid volume homeostasis in heart failure: a tale of 2 circulations.

5 Dec, 2022 | 00:00h | UTC

Fluid Volume Homeostasis in Heart Failure: A Tale of 2 Circulations – Journal of the American Heart Association

 


M-A | Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment.

2 Dec, 2022 | 14:31h | UTC

Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials – Frontiers in Cardiovascular Medicine

 


Epidemiology of heart failure in young adults: a French nationwide cohort study.

2 Dec, 2022 | 14:19h | UTC

Epidemiology of heart failure in young adults: a French nationwide cohort study – European Heart Journal

 


M-A | Sodium restriction in patients with heart failure.

1 Dec, 2022 | 14:08h | UTC

Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials – Circulation: Heart Failure (link to abstract – $ for full-text)

Commentary: Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms – TCTMD

 

Commentary on Twitter

 


2ry analysis of a RCT | Decongestion with acetazolamide in acute heart failure across the spectrum of left ventricular EF.

25 Nov, 2022 | 12:45h | UTC

Decongestion with Acetazolamide in Acute Decompensated Heart Failure across the Spectrum of Left Ventricular Ejection Fraction: a Pre-specified Analysis from the ADVOR trial – Circulation

Original Study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.

 

Commentary on Twitter

 


RCT | Impact of empagliflozin on decongestion in acute heart failure.

23 Nov, 2022 | 14:04h | UTC

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial – European Heart Journal

Commentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology

 

Commentary on Twitter

 

Under a https://creativecommons.org/licenses/by-nc/4.0/ license

 


Cohort Study | Prognostic prediction of genotype vs. phenotype in genetic cardiomyopathies.

23 Nov, 2022 | 13:57h | UTC

Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies – Journal of the American College of Cardiology

 

Commentary on Twitter

 

Under a Creative Commons license

 


Right heart failure in the ED: approach to diagnosis and management.

23 Nov, 2022 | 13:54h | UTC

Right Heart Failure in the ED: Approach to Diagnosis and Management – emDocs

 


RCT | Influenza vaccine to reduce adverse vascular events in patients with heart failure.

18 Nov, 2022 | 13:26h | UTC

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial – The Lancet Global Health

Commentary: 

Flu vaccines cut pneumonia, cardiovascular issues in heart failure patients – CIDRAP

Flu Shot Could Be Lifesaver for Folks With Heart Failure – HealthDay

 


M-A | Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction.

18 Nov, 2022 | 13:14h | UTC

Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction: an updated systematic review and network meta-analysis of randomized controlled trials – Cardiovascular Diabetology

 


RCT | Early routine use of ECMO fails to improve outcomes in patients with cardiogenic shock.

11 Nov, 2022 | 14:01h | UTC

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial – Circulation

Commentaries:

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes – News Medical/American Heart Association

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock – TCTMD

Immediate Use of ECMO Did Not Improve Outcomes in Patients with Cardiogenic Shock – HCP Live

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.